Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -7.19% is 92% above its 5-year average of -87.60%, near the high end of its 5-year range (-269.43%–10.23%).
5.20% below its 12-month average of -6.83%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.43%.
OPERATING MARGIN
-7.19%
OPERATING MARGIN AVG TTM
-6.83%
OPERATING MARGIN AVG 3Y
-8.27%
OPERATING MARGIN AVG 5Y
-87.60%
OPERATING MARGIN AVG 10Y
-168.30%
OPERATING MARGIN AVG 15Y
-105.34%
OPERATING MARGIN AVG 20Y
-144.79%
CURRENT VS TTM AVG
-5.20%
CURRENT VS 3Y AVG
+13.09%
CURRENT VS 5Y AVG
+91.79%
CURRENT VS 10Y AVG
+95.73%
CURRENT VS 15Y AVG
+93.17%
CURRENT VS 20Y AVG
+95.03%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 747 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Heron Therapeutics, Inc.
Market Cap
$64.85M
Operating Margin
-7.19%
TTM Avg
-6.83%
3Y Avg
-8.27%
5Y Avg
-87.60%
Market Cap
$64.83M
Operating Margin
-336.81%
TTM Avg
-194.53%
3Y Avg
-97.26%
5Y Avg
-64.84%
Market Cap
$63.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3242.03%
5Y Avg
-2392.63%
Market Cap
$66.23M
Operating Margin
-1113.98%
TTM Avg
-13312.81%
3Y Avg
-6656.40%
5Y Avg
-4437.60%
Market Cap
$63.23M
Operating Margin
-69.62%
TTM Avg
-71.11%
3Y Avg
-78.39%
5Y Avg
-54.75%
Market Cap
$63.14M
Operating Margin
2.49%
TTM Avg
-12.82%
3Y Avg
-6.08%
5Y Avg
-11.76%
Market Cap
$67.38M
Operating Margin
-1.72%
TTM Avg
3.29%
3Y Avg
-3.87%
5Y Avg
-2.22%
Market Cap
$61.16M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | $64.85M | -7.19% | -6.83% | -8.27% | -87.60% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.83M | -336.81% | -194.53% | -97.26% | -64.84% |
| Cingulate Inc. (CING)vs › | $65.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | -3242.03% | -2392.63% |
| RenovoRx, Inc. (RNXT)vs › | $66.23M | -1113.98% | -13312.81% | -6656.40% | -4437.60% |
| Alps Group Inc (ALPS)vs › | $63.23M | -69.62% | -71.11% | -78.39% | -54.75% |
| InterCure Ltd. (INCR)vs › | $63.14M | 2.49% | -12.82% | -6.08% | -11.76% |
| Champions Oncology, Inc. (CSBR)vs › | $67.38M | -1.72% | 3.29% | -3.87% | -2.22% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.16M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | -111.00% | -151.19% | -184.89% | -203.40% |
Gross Margin
70.1%
Operating Margin
-7.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -5.43% |
| 2026-03-31 | -13.73% |
| 2025-12-31 | 0.09% |
| 2025-09-30 | -10.71% |
| 2025-06-30 | -4.40% |
| 2025-03-31 | 8.11% |
| 2024-12-31 | 10.23% |
| 2024-09-30 | -13.59% |
| 2024-06-30 | -17.89% |
| 2024-03-31 | -13.84% |
| 2023-12-31 | -29.85% |
| 2023-09-30 | -79.31% |
| 2023-06-30 | -133.50% |
| 2023-03-31 | -111.64% |
| 2022-12-31 | -67.79% |
| 2022-09-30 | -157.71% |
| 2022-06-30 | -179.15% |
| 2022-03-31 | -268.25% |
| 2021-12-31 | -259.20% |
| 2021-09-30 | -222.59% |
| 2021-06-30 | -269.43% |
| 2021-03-31 | -260.34% |
| 2020-12-31 | -297.48% |
| 2020-09-30 | -292.43% |
| 2020-06-30 | -245.94% |
| 2020-03-31 | -207.61% |
| 2019-12-31 | -169.20% |
| 2019-09-30 | -81.77% |
| 2019-06-30 | -141.24% |
| 2019-03-31 | -204.73% |
| 2018-12-31 | -177.90% |
| 2018-09-30 | -211.16% |
| 2018-06-30 | -224.88% |
| 2018-03-31 | -449.47% |
| 2017-12-31 | -615.64% |
| 2017-09-30 | -481.96% |
| 2017-06-30 | -494.18% |
| 2017-03-31 | -1357.35% |
| 2016-12-31 | -3659.34% |
| 2016-09-30 | -7221.48% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | -118.97% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | -613.55% |
| 2011-03-31 | -332.91% |
| 2010-12-31 | -968.16% |
| 2010-09-30 | -465.81% |
| 2010-06-30 | -697.17% |
| 2010-03-31 | -1191.29% |
| 2009-12-31 | -1721.31% |
| 2009-09-30 | -108.59% |
| 2009-06-30 | -28285.71% |
| 2009-03-31 | -37112.50% |
| 2008-12-31 | -18242.86% |
| 2008-09-30 | -9807.81% |
| 2008-06-30 | -4111.18% |
| 2008-03-31 | -5328.57% |
| 2007-12-31 | -5921.21% |
| 2007-09-30 | -4327.27% |
| 2007-06-30 | -2796.88% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | -185.25% |
| 2005-09-30 | -137.40% |
| 2005-06-30 | -212.08% |
| 2005-03-31 | -96.40% |
| 2004-12-31 | -157.76% |
| 2004-09-30 | -134.29% |
| 2004-06-30 | -190.11% |
| 2004-03-31 | -218.56% |
| 2003-12-31 | -111.78% |
| 2003-09-30 | -97.40% |
| 2003-06-30 | -177.62% |
| 2003-03-31 | -169.44% |
| 2002-12-31 | -25.28% |
| 2002-09-30 | -107.52% |
